Recombinant multi-species NPR3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NPR3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
The Alternative Names of target: ANP-C,ANP-CR,ANPR-C,ANPRC,Atrial natriuretic peptide clearance receptor,Atrial natriuretic peptide receptor 3,Atrial natriuretic peptide receptor type C (ANP-C,BOMOS,C5orf23,EF-2,GUCY2B,NPR-C,NPR-C),NPR3,NPRC,Npr3,lgj,stri

Target products collectionGo to NPR3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0075-Ag-1/ GM-Tg-hg-IP0075-Ag-2 Human NPR3 protein Human
GM-Tg-rg-IP0075-Ag-1/ GM-Tg-rg-IP0075-Ag-2 Rat NPR3 protein Rat
GM-Tg-mg-IP0075-Ag-1/ GM-Tg-mg-IP0075-Ag-2 Mouse NPR3 protein Mouse
GM-Tg-cynog-IP0075-Ag-1/ GM-Tg-cynog-IP0075-Ag-2 Cynomolgus/Rhesus macaque NPR3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0075-Ag-1/ GM-Tg-felg-IP0075-Ag-2 Feline NPR3 protein Feline
GM-Tg-cang-IP0075-Ag-1/ GM-Tg-cang-IP0075-Ag-2 Canine NPR3 protein Canine
GM-Tg-bovg-IP0075-Ag-1/ GM-Tg-bovg-IP0075-Ag-2 Bovine NPR3 protein Bovine
GM-Tg-equg-IP0075-Ag-1/ GM-Tg-equg-IP0075-Ag-2 Equine NPR3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0075-Ag-1/ GM-Tg-hg-IP0075-Ag-2; GM-Tg-rg-IP0075-Ag-1/ GM-Tg-rg-IP0075-Ag-2;
GM-Tg-mg-IP0075-Ag-1/ GM-Tg-mg-IP0075-Ag-2; GM-Tg-cynog-IP0075-Ag-1/ GM-Tg-cynog-IP0075-Ag-2;
GM-Tg-felg-IP0075-Ag-1/ GM-Tg-felg-IP0075-Ag-2; GM-Tg-cang-IP0075-Ag-1/ GM-Tg-cang-IP0075-Ag-2;
GM-Tg-bovg-IP0075-Ag-1/ GM-Tg-bovg-IP0075-Ag-2; GM-Tg-equg-IP0075-Ag-1/ GM-Tg-equg-IP0075-Ag-2
Products Name NPR3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NPR3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NPR3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.